Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 1SANOFI CHIMIE Gentilly FR
01 1Ketoprofen
01 1France
01 1Withdrawn by Holder
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Certificate Number : R2-CEP 1994-021 - Rev 03
Status : Withdrawn by Holder
Issue Date : 2010-05-06
Type : Chemical
Substance Number : 922
20
Sanofi Chimie Gentilly Fr, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their significant offerings is Ketoprofen, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R2-CEP 1994-021 - Rev 03
This Chemical Type CEP, issued on May 06, 2010, remains in force until March 12, 2019, ensuring its reliability within the pharmaceutical industry.
Substance Number 922 associated with this CEP further emphasizes
LOOKING FOR A SUPPLIER?
